Incidence and Impact of Ventilator Associated Multidrug Resistant Pneumonia in Patients with SARS-COV2

Table 2

Multivariate (MLR) regression analyses for factors associated with VAP.

	Mortality		Hospital LOS (days)		ICU LOS (days)
	MLR OR		MLR coef		MLR coef
VAP			14.6	0.008	13.4	0.003
Age	1.05	0.01	−0.2	0.08	−0.2	0.03
PMH
Cancer	2.7	0.09	−0.9	0.8	−1.4	0.6
Heart disease	1.3	0.5
BMI	0.9	0.02	0.02	0.9	0.04	0.7
Chronic liver disease	3.6	0.03
DM			4.8	0.7	4.1	0.7
Immunosuppression					−6.7	0.048
African American			−1.4	0.6	−0.9	0.7
Antibiotics (intubation)			4.7	0.1	4.0	0.1
Antibiotics (at final diagnosis)			1.4	0.8	−2.1	0.6
SOFA (hospital admit)			−0.2	0.4	−0.2	0.3
SOFA (ICU admit)	1.3	<0.001

Only variables with univariate regression were included in multi-logistic regression. VAP–ventilator associated pneumonia; LOS–length of stay; MLR–multivariate regression; PMH–past medical history; BMI–body mass index; Dm–diabetes mellitus; SOFA–sequential organ failure assessment; ICU–intensive care unit.